ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Prime Medicine Inc

Prime Medicine Inc (PRME)

2.775
0.18
( 6.94% )
Updated: 11:37:28
Advanced chart
Rendering Error

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.775
Bid
2.77
Ask
2.78
Volume
779,389
2.66 Day's Range 2.90
2.25 52 Week Range 9.77
Market Cap
Previous Close
2.595
Open
2.66
Last Trade
4
@
2.775
Last Trade Time
11:39:48
Financial Volume
$ 2,161,622
VWAP
2.7735
Average Volume (3m)
1,083,167
Shares Outstanding
131,160,842
Dividend Yield
-
PE Ratio
-1.84
Earnings Per Share (EPS)
-1.51
Revenue
-
Net Profit
-198.13M

About Prime Medicine Inc

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome a... Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Prime Medicine Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PRME. The last closing price for Prime Medicine was $2.60. Over the last year, Prime Medicine shares have traded in a share price range of $ 2.25 to $ 9.77.

Prime Medicine currently has 131,160,842 shares outstanding. The market capitalization of Prime Medicine is $340.36 million. Prime Medicine has a price to earnings ratio (PE ratio) of -1.84.

PRME Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.2459.68379446642.532.92.2510818022.44455466CS
4-0.125-4.310344827592.93.342.259521192.70243643CS
12-0.265-8.717105263163.043.592.2510831672.94613835CS
26-1.575-36.20689655174.355.022.2512845773.51156369CS
52-4.015-59.13107511056.799.772.2510517504.60938862CS
156-16.195-85.371639430718.9721.73012.256652056.93718201CS
260-16.195-85.371639430718.9721.73012.256652056.93718201CS

PRME - Frequently Asked Questions (FAQ)

What is the current Prime Medicine share price?
The current share price of Prime Medicine is $ 2.775
How many Prime Medicine shares are in issue?
Prime Medicine has 131,160,842 shares in issue
What is the market cap of Prime Medicine?
The market capitalisation of Prime Medicine is USD 340.36M
What is the 1 year trading range for Prime Medicine share price?
Prime Medicine has traded in the range of $ 2.25 to $ 9.77 during the past year
What is the PE ratio of Prime Medicine?
The price to earnings ratio of Prime Medicine is -1.84
What is the reporting currency for Prime Medicine?
Prime Medicine reports financial results in USD
What is the latest annual profit for Prime Medicine?
The latest annual profit of Prime Medicine is USD -198.13M
What is the registered address of Prime Medicine?
The registered address for Prime Medicine is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Prime Medicine website address?
The website address for Prime Medicine is www.primemedicine.com
Which industry sector does Prime Medicine operate in?
Prime Medicine operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
$ 5.57
(115.89%)
69.83M
PTPIPetros Pharmaceuticals Inc
$ 0.5079
(105.21%)
7.93M
WRDWeRide Inc
$ 33.3133
(94.02%)
15.05M
SPGCSacks Parente Golf Inc
$ 1.10
(84.75%)
67.97M
SRMSRM Entertainment Inc
$ 0.63
(75.98%)
204.09M
NEXNNexxen International Ltd
$ 10.20
(-49.65%)
61k
BSLKBolt Projects Holdings Inc
$ 0.6633
(-46.07%)
8.95M
BLACBellevue Life Sciences Acquisition Corporation
$ 3.9071
(-44.58%)
111.44k
BLACUBellevue Life Sciences Acquisition Corporation
$ 4.00
(-43.66%)
1.66k
SERVServe Robotics Inc
$ 13.50
(-41.10%)
37.96M
CNSPCNS Pharmaceuticals Inc
$ 0.139
(28.94%)
409.21M
MGOLMGO Global Inc
$ 1.085
(28.40%)
219.27M
SRMSRM Entertainment Inc
$ 0.63
(75.98%)
198.18M
INTCIntel Corporation
$ 23.3149
(-3.38%)
113.02M
MBRXMoleculin Biotech Inc
$ 1.972
(55.28%)
112.94M

PRME Financials

Financials
Rendering Error

PRME Discussion

View Posts
Monksdream Monksdream 2 months ago
PRME, under $

👍️0
PonkenPlonken PonkenPlonken 2 months ago
Super super undervalued..
Recent PSTX - Roche deal should have made this run? Atleast given it also recently partnered with BMS... makes zero sense.
Is a clear validation CRISPR genome editing is hot in cancer cell therapy.
Waiting for a sign....
👍️0
Monksdream Monksdream 4 months ago
PRME under $5
👍️0
Monksdream Monksdream 4 months ago
PRME new 52 week low
👍️0
Invest-in-America Invest-in-America 5 months ago
PRME: Glad I grabbed a chunk of THIS ONE!!!!
👍️0
PonkenPlonken PonkenPlonken 5 months ago
"Under the terms of the agreement, Prime Medicine will receive a $55 million upfront payment and a $55 million equity investment from Bristol Myers Squibb. Prime Medicine is also eligible to receive more than $3.5 billion in milestones,..."

"On the Effective Date, the Company entered into the Purchase Agreement with BMS, pursuant to which the Company agreed to issue and sell, and BMS agreed to purchase, in an unregistered offering (the “Offering”), 11,006,163 shares [...] for an aggregate purchase price of $55.0 million..."
👍️0
Monksdream Monksdream 5 months ago
PRME new 52=week low
👍️0
wiwineguy wiwineguy 5 months ago
K. I'm in!
👍️0
Monksdream Monksdream 5 months ago
DAKT
👍️0
wiwineguy wiwineguy 5 months ago
You are amazing Monk. Any recommendations
👍️0
Monksdream Monksdream 5 months ago
PRME under $5
👍️0
Monksdream Monksdream 6 months ago
PRME new 52 week low
👍️0
Monksdream Monksdream 7 months ago
PRME under $6
👍️0
Monksdream Monksdream 7 months ago
PRME under $10:
👍️0
Monksdream Monksdream 8 months ago
Great post
Friday Cathie Wood bought more shares for her flagship Ark Fund (ARKK)
I think she has been buying on the decline
She isn’t particularly interested in how well or how lousy the management controls costs it’s the potential she believes exists
There are about a dozen, if not more, listed gene editing companies
Not all will make it before they run out of money and have to raise more operating capital
Notice the $2 to $4 bounces on the way to lower lows
👍️0
Monksdream Monksdream 9 months ago
PRME under $10
👍️0
jondoeuk jondoeuk 9 months ago
PRME vs Tome vs Tessera vs NTLA vs CRSP vs...!

They fact this article needs to be written could mean a legal battle is coming https://www.nature.com/articles/s41587-024-02208-0
👍️0
NY1972 NY1972 10 months ago
This $500M company burns $200M a year. These PhDs have been spoiled by Wall St. when money was cheap. Who wants to be their sugar daddy?
👍️0
jondoeuk jondoeuk 10 months ago
I'm sure in the (near) future they will (functionally) cure (rare) diseases, but not before they dilute a whole bunch more.
👍️0
jondoeuk jondoeuk 12 months ago
The CEO has been contently telling investors how easy it would be to bring in funding through partnerships and how difficult capital markets are. Yet they did a secondary. He needs to go. Also, I don't think their IP is gatekeeping others.
👍️0